{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:28:26Z","timestamp":1790692106291,"version":"4.1.0"},"reference-count":75,"publisher":"Informa UK Limited","issue":"15","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.2217\/imt-2022-0085","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T08:14:11Z","timestamp":1660119251000},"page":"1191-1204","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":39,"title":["Sutimlimab for Treatment of Cold Agglutinin Disease: Why, How And For Whom?"],"prefix":"10.1080","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3425-4653","authenticated-orcid":false,"given":"Sigbj\u00f8rn","family":"Berentsen","sequence":"first","affiliation":[{"name":"Department of Research and Innovation, Haugesund Hospital, Helse Fonna Hospital Trust, Haugesund, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Barcellini","sequence":"additional","affiliation":[{"name":"Hematology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"D\u2019Sa","sequence":"additional","affiliation":[{"name":"University College London Hospitals Centre for Waldenstr\u00f6m and Associated Conditions, University College London Hospitals National Health Service Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-583021"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6281.2023"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100648"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2033982"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005674"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26196"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.091702"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001608"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15063"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00590"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2021.11.001"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16765"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027760"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00859-8"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108547"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-556027"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040620719873321"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2015.02.001"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2001.00960.x"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-474437"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-2-238"},{"key":"e_1_3_3_26_1","first-page":"1610632","article-title":"Development of multiple myeloma of the IgA type in a patient with cold agglutinin disease: transformation or coincidence?","volume":"2019","author":"Sefland \u00d8","year":"2019","unstructured":"Sefland \u00d8 , RandenU , BerentsenS. Development of multiple myeloma of the IgA type in a patient with cold agglutinin disease: transformation or coincidence?Case Rep. Hematol.2019, 1610632 (2019).","journal-title":"Case Rep. Hematol."},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003809"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000036"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/hemato2030029"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16745"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001321"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2012.12.001"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26409"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-219066"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100799"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-094136"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279812"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25932"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12333"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024190"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3597"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500286481"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-778175"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-288647"},{"key":"e_1_3_3_45_1","unstructured":"UpToDate . Cold agglutinin disease (2022). www.uptodate.com\/contents\/cold-agglutinin-disease?search=cold%20agglutinin%20disease&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-835413"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012039"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2003.00004.x"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14478"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220604"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04969-2"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000433"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-01-894303"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-11-467209"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.14740\/jh242w"},{"issue":"3","key":"e_1_3_3_56_1","first-page":"2690","article-title":"Peritransfusional C1-inhibitor in patients with severe complement-mediated autoimmune hemolytic anemia: an open-label phase 2 trial. Presented at the European Hematology Association 2022 Congress","volume":"6","author":"De Boer ECV","year":"2022","unstructured":"De Boer ECV , JalinkM , Delvasto-Nu\u00f1esLet al. Peritransfusional C1-inhibitor in patients with severe complement-mediated autoimmune hemolytic anemia: an open-label phase 2 trial. Presented at the European Hematology Association 2022 Congress. Hemasphere6(S3), 2690 (2022).","journal-title":"Hemasphere"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-196329"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0564"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061648"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029073"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-119468"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/1091581817740873"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1265.1265"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.028"},{"key":"e_1_3_3_65_1","unstructured":"Sanofi Genzyme . Enjaymo prescribing information (2022). (Accessed 19March2022). www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/761164s000lbl.pdf?utm_medium=email&utm_source=govdelivery"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2018.04.002"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001804"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.12.017"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1111"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2155"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-06-856930"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014955"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18289"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309346508"},{"key":"e_1_3_3_75_1","unstructured":"CDC . Altered immunocompetence: general best practice guidelines for immunization: best practices guidance of the Advisory Committee on Immunization Practices (ACIP) (2022). (Accessed 27June2022). www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/immunocompetence.html#ref-02"},{"key":"e_1_3_3_76_1","unstructured":"US FDA . FDA approves treatment for adults with rare type of anemia (2022). www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-treatment-adults-rare-type-anemia"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14051035"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2022-0085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:58:29Z","timestamp":1715954309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2022-0085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":75,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.2217\/imt-2022-0085"],"URL":"https:\/\/doi.org\/10.2217\/imt-2022-0085","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-04-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}